• Accueil
• tpex
• ASLAN moves primary listing from TPEx to Nasdaq

ASLAN moves primary listing from TPEx to Nasdaq

4.8 (764) · € 16.50 · En Stock

SEC Filing ASLAN Pharmaceuticals

asln-20f_20201231.htm

SEC Filing Belite Bio, Inc.

Jan 2022

F-1

SEC Filing Belite Bio, Inc.

SJS 2022 Dimensions - Flipbook by Edspire

SEC Filing ASLAN Pharmaceuticals

asln-20f_20181231.htm

Inline XBRL Viewer

Texas Pacific Land: 'Buy Land, They're Not Making It Anymore

Texas Pacific Land: 'Buy Land, They're Not Making It Anymore

Life Pre- and Post-IPO: The journey of iX Biopharma and ASLAN

ASLAN moves primary listing from TPEx to Nasdaq